<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-136011</identifier>
<setSpec>0210-5691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): Oncohematological patient</dc:title>
<dc:description xml:lang="en">Patients with cancer, irrespective of the stage of their disease, can require admission to the intensive care unit as a result of the complications of their underlying processor the surgical or pharmacological treatment provided. The cancer itself, as well as the critical status that can result from the complications of the disease, frequently lead to a high degree of hypermetabolism and inadequate energy intake, causing a high incidence of malnutrition in these patients. Moreover, cancer causes anomalous use of nutritional substrates and therefore the route of administration and proportion and intake of nutrients may differ in these patients from those in non-cancer patients (AU)</dc:description>
<dc:creator>Planas, M</dc:creator>
<dc:creator>Fernández-Ortega, J. F</dc:creator>
<dc:creator>Abilés, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los pacientes portadores de cáncer, en cualquier fase de su evolución, pueden precisar ingreso en UCI como consecuencia de complicaciones secundarias a su enfermedad de base o de las terapias quirúrgicas o farmacológicas a que se ven sometidos para tratar su enfermedad. La propia enfermedad cancerosa, así como el estado crítico a que pueden derivar como consecuencia de las complicaciones sobreañadidas, con frecuencia condicionan un alto grado de hipermetabolismo y de déficit de ingesta nutricional, lo que conduce en estos enfermos a una alta incidencia de desnutrición. Además, la propia enfermedad cancerosa condiciona una utilización anómala de los sustratos nutritivos, lo que podría condicionar una vía de administración y una proporción y aporte de nutrientes algo diferenciado de los pacientes no tumorales (AU)</dc:description>
<dc:source>Med. intensiva (Madr., Ed. impr.);35(supl.1): 53-56, nov. 2011.</dc:source>
<dc:identifier>ibc-136011</dc:identifier>
<dc:title xml:lang="es">Recomendaciones para el soporte nutricional y metabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Paciente oncohematológico</dc:title>
<dc:subject>^d^s22045</dc:subject>
<dc:subject>^d13342^s22048</dc:subject>
<dc:subject>^d29627</dc:subject>
<dc:subject>^d9935</dc:subject>
<dc:subject>^d9562^s22009</dc:subject>
<dc:subject>^d2134^s22054</dc:subject>
<dc:subject>^d3439^s22045</dc:subject>
<dc:subject>^d30401^s22048</dc:subject>
<dc:subject>^d6117^s22000</dc:subject>
<dc:subject>^d30291</dc:subject>
<dc:subject>^d9562^s22012</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d30401^s22045</dc:subject>
<dc:subject>^d7426^s22054</dc:subject>
<dc:subject>^d13339^s22048</dc:subject>
<dc:subject>^d2134^s22027</dc:subject>
<dc:subject>^d28024^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30170^s22067</dc:subject>
<dc:subject>^d23101^s22000</dc:subject>
<dc:subject>^d4813</dc:subject>
<dc:subject>^d30324^s22048</dc:subject>
<dc:subject>^d9562^s22067</dc:subject>
<dc:subject>^d30324^s22045</dc:subject>
<dc:subject>^d6117^s22073</dc:subject>
<dc:subject>^d9562^s22044</dc:subject>
<dc:subject>^d2181</dc:subject>
<dc:type>article</dc:type>
<dc:date>201111</dc:date>
</metadata>
</record>
</ibecs-document>
